Class I โ€” Serious Health Hazard

Serious health hazard โ€” there is a reasonable probability that use of or exposure to this product will cause serious adverse health consequences or death.

XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Recalled by Atlantic Pro Nutrients, Inc. dba XYMOGEN Due to Undeclared Soy

Date: May 1, 2013
Company: Atlantic Pro Nutrients, Inc. dba XYMOGEN
Status: Terminated
Source: FDA (Food)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Atlantic Pro Nutrients, Inc. dba XYMOGEN directly.

Affected Products

XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and 180 capsule bottles

Quantity: 16,268 units

Why Was This Recalled?

Undeclared Soy and Milk on the label.

Where Was This Sold?

This product was distributed to 40 states: AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, NJ, NM, NY, NC, OH, OK, PA, RI, SC, TN, TX, UT, VA, WA, WV, WI, WY

Affected (40 states)Not affected

About Atlantic Pro Nutrients, Inc. dba XYMOGEN

Atlantic Pro Nutrients, Inc. dba XYMOGEN has 3 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Food). Last updated March 26, 2026. View original report